Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

UnitedHealth Group : Today’s Research Reports on Trending Tickers: UnitedHealth Group and Novartis

share with twitter share with LinkedIn share with facebook
share via e-mail
02/20/2018 | 02:05pm CET

NEW YORK, NY / ACCESSWIRE / February 20, 2018 / U.S. markets closed Friday with weekly gains in the range of 4 percent to 5 percent. The Dow Jones Industrial Average gained 0.08 percent to close at 25,219.38, while the S&P 500 increased 0.04 percent to close at 2,732.22. Both, Dow and S&P 500 were up 4.3 percent for the week. The Nasdaq Composite Index dropped 0.23 percent to close at 7,239.47, however posting weekly gains of 5.3 percent. With trading closed on Monday to celebrate President's Day, investors had some time to analyze recent events.

"Events over the past few weeks serve as a salutary reminder of both the dangers of crowded positions and of the power of technical forces when combined with consensual positioning," said Erin Browne, head of asset allocation at UBS.

RDI Initiates Coverage on:

UnitedHealth Group Inc.


Novartis AG

UnitedHealth Group's stock moved 1.48% higher Friday, to close the day at $229.37. The stock recorded a trading volume of 3,621,676 shares, which was above its three months average volume of 3,609,367 shares. In the last year, UnitedHealth Group's shares have traded in a range of 157.52 - 250.79. The share price has gained 45.61% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $231.66 is greater than its 200-day moving average of $211.76. Shares of UnitedHealth Group are trading at a Price to Earnings ratio of 21.40. Shares of UnitedHealth Group have fallen roughly 5.74 percent in the past month and are up 4.04 percent year-to-date.

Access RDI's UnitedHealth Group Inc. Research Report at:

On Friday, shares of Novartis recorded a trading volume of 983,166 shares, which was below the three months average volume of 1,444,301 shares. The stock ended the day 0.27% higher at 86.91. The share price has gained 19.60% from its 52 week low with a 52 week trading range of 72.67 - 94.19. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $87.11 is greater than its 200-day moving average of $84.99. Shares of the company are trading at a Price to Earnings ratio of 26.74. Shares of Novartis have fallen roughly 0.03 percent in the past month and are up 3.51 percent year-to-date.

Access RDI's Novartis AG Research Report at:

Our Actionable Research on UnitedHealth Group Inc. (NYSE:UNH) and Novartis AG (NYSE:NVS) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.


For any questions, inquiries, or comments reach out to us directly at:


Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011


[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

© Accesswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
02/20UNITEDHEALTH GROUP : Today’s Research Reports on Trending Tickers: UnitedHealth ..
02/19UNITEDHEALTH : United Health Foundation, Cankdeska Cikana Community College Laun..
02/16UNITED HEALTH FOUNDATION : Cankdeska Cikana Community College Launch New $1.2 Mi..
02/16UNITEDHEALTH GROUP INCORPORATED (NYS : UNH) Files An 8-K Departure of Directors ..
02/15UNITEDHEALTH GROUP INC : Change in Directors or Principal Officers, Financial St..
02/15DOW MOVERS : Unh, csco
02/15UNITEDHEALTH : William McNabb Joins UnitedHealth Group Board of Directors
02/14UNITEDHEALTH GROUP : Board Authorizes Payment of Quarterly Dividend to Sharehold..
02/13UNITEDHEALTH : Judge allows UnitedHealth Medicare fraud case to proceed
02/12UNITEDHEALTHCARE : Donates $25,000 to Support East Carolina University College o..
More news
News from SeekingAlpha
02/21Tracking David Tepper's Appaloosa Management Portfolio - Q4 2017 Update 
02/20HHS debuts new rule allowing increased access to short-term insurance plans 
02/20Deflation Coming In Healthcare 
02/20Healthcare Innovation Or Exacerbating The Crisis? 
02/19Healthcare In Transition 
Financials ($)
Sales 2018 225 B
EBIT 2018 17 471 M
Net income 2018 11 440 M
Debt 2018 15 218 M
Yield 2018 1,27%
P/E ratio 2018 19,17
P/E ratio 2019 16,87
EV / Sales 2018 1,04x
EV / Sales 2019 0,94x
Capitalization 218 B
Duration : Period :
UnitedHealth Group Technical Analysis Chart | UNH | US91324P1021 | 4-Traders
Technical analysis trends UNITEDHEALTH GROUP
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 22
Average target price 271 $
Spread / Average Target 20%
EPS Revisions
David Scott Wichmann President, Chief Executive Officer & Director
Stephen J. Hemsley Executive Chairman
John Franklin Rex Chief Financial Officer
Richard J. Migliori Chief Medical Officer & EVP-Medical Affairs
Richard T. Burke Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTHEM INC4.45%60 344
AETNA-2.01%58 363
CIGNA-3.71%47 784
HUMANA7.82%38 429